U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07822321) titled 'Brexanolone Lifting Outcomes Of Moms' on Sept. 10.
Brief Summary: The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine:
* If LPCN 1154A reduces depressive symptoms in subjects with severe PPD
* How well LPCN 1154A is tolerated and what side effects it may cause
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Depression, Postpartum
Postpartum Depression (PPD)
Post-partum Depression
Postnatal Depression
Post-Natal Depression
Peripartum Depression
Intervention:
DRUG: LPCN 1154A
Oral LPCN 1154A tablets ...